About Us



Hereditary or Predisposition Cancer Genomics

Molecular  testing looks for specific inherited changes (mutations) in a person’s  genetic make-up. Genetic mutations may have multiple different effects  on a patient’s health. Mutations that are harmful may increase a  person’s chance, or risk, of developing a disease such as cancer.  Inherited mutations are thought to play a role in 5-10% of all cancers.  These particular conditions are considered hereditary and appropriate  genetic testing may be used to determine an individual’s risk.

Some  people inherit mutation(s) in the germline, allowing for the mutations  to be passed on from their parents and to their children. There are two  classes of cellular genes: oncogenes and tumor suppressor genes. Often,  multiple genetic mutations in a single individual are responsible for  the development of hereditary cancers.


  What is Cancer Genomics (CGx)?

The study of cancer genomes has revealed abnormalities in genes that drive the development and growth of many types of cancer. This knowledge has improved our understanding of the biology of cancer and led to new methods of diagnosing and treating the disease.

How will CGx testing benefit patients?

Genetic testing can help determine if one is at an increased risk of developing hereditary cancer. In addition, CGx test helps guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition. Accuracy of results is crucial.

Who is at an increased risk for hereditary cancer?

If you or your family have a history of any of the following:

- An individual that has more than one cancer
- An individual that has multiple close family members with a cancer diagnosis under the age of fifty
- An individual that has three or more close family members with different types of cancer
- An individual that has had family that has previously had cancer genetic testing and mutations were identified

Some people  are genetically more likely to develop certain types of cancers, and  cancer genomics helps to uncover these risks. After receiving the  patient’s DNA sample and carrying out a thorough test, we then compile  the results into an in-depth yet easy to understand report detailing all  the information you need to know. Using the most advanced sequencing  technology on the market, we provide incredibly accurate results which  physicians can then use to create a personalized therapy based on your  genome.


Our Service

Our team of HIPAA Certified representatives provide onsite assistance with educating the patient, specimen collection and intake form completion.  Our goal is to ensure and provide  courteous, professional and respectful experience for each patient who qualifies for CGX Hereditary Cancer Screening.  



CGX Training Video

Other Service

DME (Durable Medical Equipment)

We assist our Medicare Part B patients with acquiring much needed medical braces to assist with alleviating back, shoulder, knee, elbow, wrist, and ankle pain.